Brief: Cryofocus Medtech Shanghai Says US' FDA Grants Breakthrough Device Designation For Asthma Cryoablation System
24/07/2025 14:57
July 24 (Reuters) - Cryofocus Medtech Shanghai Co Ltd 6922.HK: FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION FOR ASTHMA CRYOABLATION SYSTEM Further company coverage: 6922.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cryofocus Medtech (Shanghai) Co
See all newsBrief: Cryofocus Medtech (Shanghai) To Allot & Issue 7.5 Million H Shares
Brief: Cryofocus Medtech (Shanghai) Says Anti-Gastroesophageal Reflux System Granted Approval By Nmpa
Brief: Cryofocus Medtech Shanghai Says China's NMPA Approves Registration Change Of Disposable Cryoprobe Of Cryoadhesion System
Brief: Cryofocus Medtech Shanghai Says US' FDA Grants Breakthrough Device Designation For Asthma Cryoablation System
Brief: Cryofocus Medtech Shanghai Receives NMPA Approval For Malignant Stenosis Cryoablation System